Showing results (1-10 of 596) with videos related to
Sort By:
Pageof 60
Journal of Hematology & Oncology|January 20, 2022
Momelotinib: an emerging treatment for myelofibrosis patients with anemiaHelen T Chifotides, Prithviraj Bose, Srdan VerstovsekClinical Lymphoma, Myeloma & Leukemia|February 16, 2023
SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for MyelofibrosisHelen T Chifotides, Lucia Masarova, Srdan VerstovsekExpert Opinion on Investigational Drugs|July 23, 2020
Givinostat: an emerging treatment for polycythemia veraHelen T Chifotides, Prithviraj Bose, Srdan VerstovsekCancers|July 14, 2023
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and TreatmentsHelen T Chifotides, Srdan Verstovsek, Prithviraj BoseInternational Review of Cell and Molecular Biology|February 14, 2022
Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPNSergiu Pasca, Helen T Chifotides, Srdan Verstovsek, et al.Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
SOHO State of the Art Updates and Next Questions: Novel Therapies in Development for MyelofibrosisHelen T Chifotides, Prithviraj Bose, Lucia Masarova, et al.Acta Haematologica|April 21, 2021
Accelerated Phase of Myeloproliferative NeoplasmsOmar A Shahin, Helen T Chifotides, Prithviraj Bose, et al.Cancers|July 27, 2022
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and UpdateSiba El Hussein, Helen T Chifotides, Joseph D Khoury, et al.Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
Highlights in polycythemia vera from the 2016 EHA congressSrdan VerstovsekPostgraduate Medicine|February 9, 2013
Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosisSrdan VerstovsekPageof 60